Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F)
This study investigated mutagenesis in Escherichia coli ASNase II to find a mutant with lower GLNase activity via molecular dynamics (MD) simulation. Residues with low binding energy to asparagine (Asn) and high binding energy to glutamine (Gln) were chosen for mutagenesis. A mutant with low free binding energy to Gln was then selected for molecular docking and MD studies. The results showed that V27F is a good candidate for reducing GLNase activity and that it has little effect on enzyme ASNase activity. A simulation analysis showed that the V27F mutant was more stable than the WT ASNase and that mutagenesis was quite successful.PMID:33906306 | DOI:10.31557/APJCP.2021.22.4.1137
Source: Asian Pacific Journal of Cancer Prevention - Category: Cancer & Oncology Authors: Noeman Ardalan Abbas Akhavan Sepahi Ramazan Ali Khavari-Nejad Source Type: research
More News: Acute Leukemia | Cancer | Cancer & Oncology | Child Development | Children | Gastroenteritis | Leukemia | Study